Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Jul 13, 2023 11:31am
186 Views
Post# 35539385

RE:RE:CG Oncology is worth 7x more than us

RE:RE:CG Oncology is worth 7x more than us

Any stock has its momentum.  Sometimes, years before, sometimes before real pivotal events, sometimes just after important events.  Some rallies are artificially made, some become a base for additional pushes.

No matter how you slice it, we often see 5-10x rallies when it happens.  Go check any charts.

In TLT's case, 50% into a pivotal Ph. 2, with the quality of data we have, we're more than due.  And it will only be the beginning of a larger push as it will not be based on an artificial one but on one backed by clinical data, not just hopes/wishes/manipulation, but rather one that allows for comparisons against competitors, one that can be justified because of a 3rd party (FDA) validation that brings official credibility.

 

<< Previous
Bullboard Posts
Next >>